Recent Advances in Bioreactors in Tissue Engineering and ...

Send Orders of Reprints at [email protected] Current Tissue Engineering, 2013, 2, 000-000

1

Recent Advances in Bioreactors in Tissue Engineering and Regenerative Medicine JP Ruiz*1, N Ecker1, D Pawley1 and HS Cheung1, 2 1 2

Department of Biomedical Engineering. College of Engineering. University of Miami. Coral Gables, Florida, USA; Geriatric Research, Education and Clinical Center. Miami Veteran’s Affairs Healthcare System. Miami, Florida USA Abstract: The goal of the field of tissue engineering has always been to provide constructs that can repair, replace, or aid in the healing of damaged organs and tissues. In order to do this successfully however, a close understanding of the tissue to be replaced is required, from the molecular to the systemic level. In recent years, it has been understood that the physiological environment of many tissues is modulated and maintained by a plethora of subtle mechanical, chemical, and electrical cues, all working in synch. Bioreactors serve the purpose of mimicking this physiological environment at the bench top, in an effort to precondition tissue constructs to develop better differentiation, integration and mechanical compatibility to avoid complications post transplant. However, exactly mimicking every single subtle cue that takes a part in the development of certain tissues is currently beyond our reach, as there is still a lack of understanding of said cues and interactions. Despite this, the advances in the design of bioreactors have been tremendous, from the first simple incubator to bioreactors that now incorporate a vast amount of forces and stimulation to different tissues. This review paper takes a look at the advances and development of bioreactors in the past five to ten years, as well as assesses those currently being used in the field and their efficacy in preconditioning functional tissue constructs.

Keywords: ????????????????????????????????. INTRODUCTION Since its beginning stages, the field of Tissue Engineering (TE) has had its share of obstacles to overcome. And while the years of research in the field—20 years to be exact—have overcome many of these obstacles, host integration, immune response, mechanical mismatch, and upscaling remain critical issues that the field needs to address. Tissue Engineering was originally defined by two fathers of the field, Langer and Vacanti, as “an interdisciplinary field that applies the principles of engineering and the life sciences toward the development of biological substitutes that restore, maintain, or improve tissue function” [1]. To this day, this remains the most concise definition which most clearly defines the field and its goals. In order to successfully restore, maintain, and improve tissue function however, a clear understanding of the tissue in question is required. From before the inception of tissue engineering as a field and more so during recent years, it has been understood that a tissue’s environment is maintained and developed by many mechanical, chemical, and electrical cues. Mechanotransduction, for example, is a cell or tissue’s ability to receive and interpret mechanical cues and translate those cues into chemical intracellular cues that affect a cell’s phenotypic expression [2]. The complexity of the cues is addressed in tissue engineering from many angles, from scaffold and cell type, to pre-transplantation conditioning [3]. While we are nowhere

close to deciphering and understanding exactly every single one of these minute cues that controls the development and functions of tissues, we have been able to mimic some of these cues in order to address some of the issues associated with tissue engineering. Bioreactors are “tissue-culture devices that provide a controllable, mechanically active environment that can be used to study and potentially improve engineered tissue structure, properties, and integration” [4]. From the simple lab bench incubator to the most complex of bioreactors, the goal remains the same: controlling one or multiple aspects of a cell’s environment in order to aid in the development of the tissue. Taking advantage of mechanotransduction for example, many bioreactors apply different types of mechanical forces to stimulate the cells and developing tissues [5]. This kind of bioreactor has been employed as early as the 80’s for myofibroblast research [6], until today, with a recent study using mechanical stretching to stimulate corneal constructs [7]. The field of Tissue Engineering has tried to design replacement tissue for almost every tissue for which there is a major disease paradigm. Because of this, the applications of bioreactors are almost limitless. This review however, focuses on the design and development of bioreactors during the past five to ten years, in fields which bioreactor application has had a large impact: skeletal muscle, cardiovascular tissues, bone, cartilage, and neural tissues. SKELETAL MUSCLE BIOREACTORS

*Address correspondence to this author at the Department of Biomedical Engineering. College of Engineering. University of Miami. Coral Gables, Florida, USA; Tel/Fax: ?????????????; E-mail: ??????????????? 2211-5420/13 $58.00+.00

The field of skeletal muscle engineering differs slightly from those of the other muscle tissue counterparts. Unlike smooth muscle, skeletal muscle needs to react to and pro© 2013 Bentham Science Publishers

2

Current Tissue Engineering, 2013, Vol. 2, No. 2

Ruiz et al.

duce higher levels of force. And although it is similar to cardiac muscle in that it can be stimulated through electrical and mechanical means, the paradigms for producing functional skeletal muscle constructs are much better understood than those needed to produce functional cardiac constructs. One of the reasons for this is that, unlike cardiac muscle, skeletal muscle has the physiological means for regeneration and healing after injury through progenitor and satellite cells [8].

and cultured cell lines as well as adult denervated cells. These studies have shown that adult myocytes are the most exciteable, but that denervated cells, while originally having a level of exciteability close to that of 4 day neonatal myocytes, regain excitability after electrical stimulation [19]. This shows the promise of electrical stimulation as a way of preloading tissue engineered muscle constructs prior to implantation in order to increase the functionality of the implanted construct.

The idea of using an outside stimulus to enervate or stimulate muscle, whether in in vivo or in vitro has been explored since the beginning of the twentieth century [9]. Because of its ability to become stimulated by electrical [10, 11] and mechanical cues however, bioreactors which stimulate myocytes through electrical or mechanical means have been the most extensively explored as viable means of preconditioning tissue engineered muscle constructs [9].

In vitro, electrical stimulation of C2C12 myocytes has been shown to accelerate sarcomere assembly through a de novo pathway [20], as well as to modulate IGF binding protein transcript levels, both critical in myogenic differentiation [21]. One group designed and developed a very affordable bioreactor system that allows for electrical stimulation of 2D and 3D myocyte cultures. Electrical stimulation with their bioreactor led to an increase in protein production in the 2D constructs and to an increase in force production and excitability in the 3D constructs [22].

Mechanical stimulation of myocytes in vitro has been explored since the late eighties in early studies that studied the physiology of cultured myocytes after dynamic mechanical stimulation. These studies saw an alignment of the majority of the culture to the uni-axial direction of strain [12]. Many more studies have been done since then. The most recent of these studies have found that stretching skeletal muscle constructs seeded with muscle precursors (typically C2C12 cells) leads to an increase in skeletal muscle phenotype as well as return of functionality when implanted in vivo. One of these studies showed that mechanical preloading of constructs leads on an increase in Myosin Heavy Chain (MHC) protein accumulation in the engineered constructs [13]. This is a protein that plays a critical role in muscle contraction, and one of the markers used for determining differentiation into muscle cell lines. Other studies have shown that uniaxial and multiaxial stress to C2C12 myocytes produces activation of similar pathways. However, multiaxial strain causes an increase in the phosphorylation of the p70Sk6 pathway where uniaxial strain does not. They also found that this particular pathway is dependent on the integrity of the myocytes’ cytoskeleton, suggesting that multiaxial stress causes cytoskeletal mechanotransduction where uniaxial stress does so through other means [14]. Another group has focused largely on seeding acellular porcine bladder scaffolds with C2C12 murine myocyte progenitors and studying the effects that dynamic stretching has on these scaffolds as treatment for Volumetric Muscle Loss. Their studies have shown that cyclic stretching in a bioreactor does in fact increase the healing rates and restores functionality close to 75% of that of the uninjured muscle [15, 16]. This same group has also done studies that showed seeding a scaffold prior to mechanical stimulation as well as following stimulation produce the fastest heal time, as well as a long-time healing paradigm [17]. This suggests that in order to produce the best healing and times and muscle repair, a mix of myocyte progenitors as well as progenitors committed to the myocyte differentiation pathway are required. Other studies that mechanically stimulate skeletal muscle tissue constructs have also been reviewed in greater detail [18]. A very recent study has shown the electrical excitability of different muscle cells, from adult and neonatal, to primary

Other bioreactor types, such as the perfusion bioreactor, have been tested on engineered muscle constructs, though few have shown as promising results as the electrical and mechanical stimulation bioreactors. Two recent studies have been done on engineered muscle constructs. These two studies saw an increase in the cell distribution throughout the scaffold as well as cell viability, and one study found an increase in the fraction of proliferating cells [23, 24]. These effects however, are known effects of the perfusion bioreactor in general, regardless of tissue or cell type. Another study tested the effects of shear stress on myocytes and found little no to no difference in treatment and control groups [14], suggesting that a perfusion bioreactor would not be ideal for this application other than to increase cell viability and distribution throughout the construct. VASCULAR BIOREACTORS It is estimated that in 2005, 17. 5 million deaths were due to cardiovascular disease [25]. Due to the large incidence of cardiovascular disease in the United States alone, the amount of research being employed to prevent, treat, and cure cardiovascular disease is predominantly large. This is true also of the amount of research working towards engineering constructs to replace cardiovascular tissue. Because of this, our review breaks the cardiovascular research into two areas— cardiac and vascular—in order to review this research in more detail. HEART VALVE The field of vascular tissue engineering mainly involves the engineering of constructs for the replacement of heart valves or vasculature. It is estimated that every year, more than 100, 000 US patients need their dysfunctional or diseased valves replaced with a prosthetic or replacement valve [26]. Because of this, there is a large market for the development of suitable replacements. The development, implementation, and success of various strategies for heart valve replacement have previously been reviewed in great detail [25-28]. Here however, we explore those methods that explicitly involve the use of some bioreactor for the preconditioning or fabrication for said heart valve replacements.

Advances in Electrospinning of Nanofibers

Because of the dynamic mechanical environment that heart valves are constantly exposed to physiologically, the in vitro mechanical stretching of engineered heart valves is thought to have an effect on cell phenotype and valve properties. It has been shown that cyclical, circumferential stretching of porcine aortic heart valve sections leads to an increase in collagen levels as well as an increase in αSmooth Muscle Actin (α-SMA) [29, 30]. Another study interestingly found that when aortic leaflet firbroblasts are seeded in 3D collagen hydrogels and stretched biaxially in an anisotropic fashion, it leads to a decrease in overall expression of α-SMA as well as Vimentin. Most of the cells however, manage to rearrange themselves orthogonally to the anisotropy of the stretching. Those that do, have an increase in α-SMA expression [31]. The results of other papers correlate with the results of this previous one, suggesting that mechanical stretching—at pathological levels of stress—leads to an decrease in α-SMA, Vimentin, and Calponin [32] as well as an increase in the expression of serotonin receptors, associated with many heart valve pathologies [33]. Because of this, as well as the fact that a heart valve’s geometry is difficult to stretch as a whole, there is only one study that we know of that has tried to stretch valves as a whole in order to precondition them prior to implantation [34]. Placing the valve over a latex tube, the tube is distended by increasing the level of fluid within the tube, thus distending the attached valve as well. This study showed that such distension led to better tensile stiffness and stiffness anisotropy. It is interesting to note however, that while all of these ex vivo studies together point to the fact that while mechanical stretch can have a positive effect on the phenotype of interstitial valvular cells, it can also be damaging to them at pathological levels of stress. The perfusion bioreactor is the most common bioreactor employed in the field of heart valve engineering, as it provides easy loading and preconditioning of the valve in physiological conditions. It also allows the researchers to test the valve’s efficacy under a variety of conditions, such as hypo and hypertension, prior to implantation. To date, many different types of perfusion bioreactors have been designed for this purpose. While most of the studies claim these bioreactors to be “special” or “novel”, all are slightly different designs to the classic perfusion pump bioreactor. One of these bioreactors, for example, was designed for real time measuring of the heart valve’s compliance during perfusion [35]. The values estimated by the software for compliance during systolic and diastolic pressure very closely resembled the values measured by traditional methods. In order to most closely resemble the systole and diastole of a beating heart, many bioreactors employ a wave generator which pumps a fluid, normally air or water, into a chamber. This chamber is separated from the main chamber (containing media) by a diaphragm, normally rubber, which distends, pushing media through the valve. The media then recycles through another chamber where it can be changed for fresh media or replenished with treatments (growth factors, stem cells, more nutrients) and then returns through another valve, which prevents flow through the return circuit during systole [35-43]. The flexibility of this kind of bioreactor lies in its ability to be loaded with most type of heart valve grafts, from those made purely of biomaterials [41-43] to ex-vivo porcine or ovine


3

grafts [35, 37-40]. Most of these studies have used this bioreactor to perfuse and seed Endothelial Cells [37, 39, 43] and other valve leaflet cells onto the constructs [41, 42] or to decellularize ex vivo xenografts [40]. These studies seem to agree that preconditioning heart valve grafts in this kind of bioreactor leads to a graft better suited for implantation, and have shown increases in anti-thrombotic behavior [39], increased cell attachment, alignment and expression of α-SMA [41], as well as collagen deposition [41, 43] and better mechanical properties [42]. Due to its versatility and ability to closely mimic physiological conditions in a controlled setting, this is probably the better bioreactor in the field of valve tissue engineering. VASCULATURE Due to the almost identical physiological conditions that both vasculature and heart valves are exposed to, research pertaining to these two fields is somewhat similar. Like replacement heart valve constructs, replacement vascular constructs need to bypass the issues of thrombosis and intimal hyperplasia, as well as have appropriate mechanical properties to avoid rupture, failure, and mechanical mismatch at the site of implantation [44]. Because of these similarities, the research that has arisen involving bioreactors for the preconditioning of vascular grafts mainly involves either mechanical stretching bioreactors and perfusion bioreactors, as with heart valve research. Unlike those bioreactors employed for heart valve research however, much of the bioreactors employed for mechanical stretching of tissue engineered vasculature include some sort of perfusion mechanism which in turn distends the constructs, providing the mechanical stretching as well as all of the advantages of regular perfusion bioreactors [45-50]. Some of these studies designed their bioreactors to cater to the perfusion of small vessel constructs [47-49]. Of these, one study was equipped to provide real-time data on the distension of the vessel constructs using a built-in LED system [47], while another seeded Endothelial Cells through perfusion, but only 13 days after the construct had been seeded with Smooth Muscle Cells, providing a layered construct similar to blood vessels [48]. Of the bioreactors designed for the larger constructs, one is worth noting in that it also incorporates rotation to minimize the effect of gravity on the cell growth and matrix deposition of the construct. This additional feature ensured a more uniform distribution of cells and matrix throughout the construct [45]. Together, these studies show that this bioreactor style for preconditioning of vascular constructs decreases thrombosis [50], increases collagen fiber anisotropy and alignment [46] increases α-SMA expression [49, 50] and compliance of the constructs [47]. Only one of the studies reviewed showed a negative effect of mechanical stretching on the mechanical properties of vascular tissue [51]. However, this was a study that used a vacuum pump to provide the levels of mechanical loading instead of a perfusiondistention bioreactor. One interesting area in which the field is headed is that of perfusing the decellularized vasculature of whole tissue constructs in order to maintain the vascular tree architecture but replace the xenogeneic or allogeneic cells of the original donor organ [52].

4


CARDIAC BIOREACTORS The field of cardiac tissue engineering is one of the faster-growing fields in tissue engineering due to the prevalence of cardiovascular disease around the world. This extensive field and the strides that have been made in it have been previously reviewed [53]. Due the abilities of cardiac muscle to become excited through both electrical and mechanical stimulation, similar to skeletal muscle, the bioreactors that have arisen for the stimulation and preloading of cardiac constructs are either mechanical or electrical bioreactors. Despite this tendency in the field to build electrical and mechanically driven bioreactors, a few studies have tried to use different bioreactor modalities for the culture and differentiation of cardiomyocytes. One of these studies tested the effects of a stirred suspension bioreactor on the differentiation of embryonic stem cells (ESCs) into beating cardiomyocytes through growth factor treatment. The study encountered an increase in the amount of spontaneously contracting embryoid bodies (EBs) as well as an increase in the total number of cardiomyocytes extracted [54]. There was also an increase in the amount of GATA-4, Myosin Heavy Chain and Myosin Light Chain expression in the cultures. Very interestingly, another study which replicated these same conditions, found that differentiating ESCs into cardiomyocytes in stirred suspension leads to cultures which, despite differentiation into spontaneously beating cardiomyocytes, retain the ability to express ESC makers, form ESC-like colonies, as well as generate teratomas [55]. Future work will need to be done, but these two studies raise questions pertaining to the role that bioreactors will play in the development of safe alternatives for the differentiation of cardiomyocytes from ESCs. As described previously, the perfusion bioreactor has been used for a variety of tissue engineering applications to uniformly seed cells onto a scaffold, as well as to provide a more homogenous level of nutrients to cells seeded throughout the scaffold. Because of these clear advantages, perfusion bioreactors have also been tested on tissue engineered cardiac constructs. Studies have, for the most part, corroborated the results of analogous studies in other fields. The perfusion bioreactor leads to an increase in viabil-

Ruiz et al.

ity of cells [56], total protein expression [57, 58] and proliferation of cells [58]. Mechanical stretching has risen to the forefront of the field as a way of preconditioning constructs in order to make their physical properties match those of the myocardium or ventricular wall, depending on the application. In data that is currently under review for publication, our group has shown that multipotent periodontal ligament-derived stem cells (PDLs), can be driven down a cardiac differentiation pathway through the sole use of cyclic mechanical stretching on a custom built bioreactor. (Fig. 1) By stretching these cells on silicon scaffolds, we were able to increase the expression of cardiac markers such as cardiac troponin-t and myosin heavy chain, among others. And while another study has also found that seeding rat neonatal cardiac myocytes in a 3D fibrin gel, and subjecting them to cyclic stretch does not have an effect on the actual physical properties of the fibrin gel, no tests were done on the phenotypic expression of the cardiomyocytes seeded on the gel [59]. These and other studies however, have paved the way for a new generation of bioreactors that now incorporate mechanical stretching to other bioreactor modalities and so create a synergistic effect with electrical stimulation. Such a mechanical stretching/electrical stimulation bioreactor is currently being designed and developed by our group. A variety of bioreactors have been designed to provide electrical stimulation to cardiac replacement constructs. Studies have been done to test these various bioreactor designs, as well as to optimize said bioreactors [60, 61]. It has been shown by different studies that electrical stimulation of cardiomyocytes and stem cells has positive effects on the development and organization of said tissue. One of these studies found that the direct application of an electrical stimulus to human embryonic cells led to the spontaneous contraction of the cells, as well as and increase in sarcomeric organization and troponin-t expression, suggesting a differentiation towards a myogenic lineage [62]. Other studies have confirmed these effects, confirming that electrical stimulation of both stem cell and cardiomyogenic lines lead to increases in proliferation, alignment, elongation, and ex-

Fig. (1). A) Double-chamber mechanical stretch bioreactor driven by stepper motor used in the stimulation of multipotent stem cells to a cardiomyogenic lineage. B) View of a single chamber with attached silicone membranes for stretching [59].


pression of cardiac markers and protein expression [63, 64]. One study went so far as to suggest using regular skeletal muscle myocytes for cardiac regeneration after electrical stimulation. While this study found an increase in the proliferation of myoblasts, they found nothing to suggest that electrical stimulation would drive the myocytes towards a more cardiac lineage [65]. Of the bioreactor designs to stimulate and preload cardiac constructs, perhaps the most interesting are the ones that most closely mimic the heart physiology and conditions. In the introduction we mention that the role of a bioreactor is to most closely mimic the various stimuli that cells receive from their environment to preload or accustom tissue engineered constructs to the in vivo environment prior to implantation. Recently, various groups have designed bioreactors which incorporate perfusion, mechanical stretching, and electrical stimulation all at once [66-69]. Of these, two incorporated electrical stimulation with constant perfusion [67, 69], and found a synergistic effect on elongation and striation as well as an increase in expression of cardiac markers such as conexin-43. Other, newer studies, incorporate all three methods: perfusion, electrical, and mechanical stimulation [66, 68]. One group has yet to do any testing of their bioreactor, as their proof-of concept merely tests for cytoxicity of the materials used and cell elongation along direction of stretch [68]. However, the other study has already shown that use of their bioreactor on rat cardiomyocytes leads to higher cardiac protein expression relative to controls [66]. These bioreactors point to the direction in which the field is headed. While no major design breakthroughs have been made in new bioreactor types, the incorporation of different bioreactor types shows the synergistic effect that different modalities have when incorporated into a single bioreactor. BONE BIOREACTORS The field of bone tissue is similar to other fields in tissue engineering in that it involves the in vitro expansion of cells on a scaffold followed by implantation into the bone. The use of bioreactors in this field is varied. Some studies use bioreactor preconditioning in order to more closely match the construct’s mechanical properties to those of the implant site. Others use a cellularized scaffold and use bioreactors to induce osteogenic differentiation. A variety of bioreactor systems including the spinner flask, perfusion, compression and rotating wall bioreactors have been implemented for the purpose of improving in vitro culturing of tissue engineered bone constructs. As described in previous sections, a spinner flask bioreactor may be used to overcome problems of uneven cellular distribution within a scaffold. It has the added benefit of providing shear stress to the cells, which has shown to have positive effects on cell proliferation and differentiation [70]. These studies on spinner flask bioreactors both seed human Mesenchymal Stem Cells (hMSCs) onto porous scaffolds. One study used a larger aqueous-derived porous silk scaffold, with enlarged pore sizes. Results saw enhanced cell proliferation, and histological analysis showed bone-like structures after 56 days of culture [71]. A similar study used a coralline hydroxyapatite scaffold with different pore sizes


5

of 220 and 500 mm for expansion. Results showed that the 200 mm pore scaffold exhibited faster osteogenic differentiation, though the 500 mm scaffold had an increased proliferation rate and a greater number of cells [70]. Both studies conclude spinner flask bioreactors are an efficient and inexpensive method for cultivating hMSCs in 3D scaffolds. Furthermore, these studies show that pore size is an important factor in controlling bone formation during dynamic cultivation [71]. This is important as larger pore sizes most likely lead to an increase in the convection and diffusion of nutrients throughout the scaffold. Besides the evident benefits of the spinner flask, one drawback is that it can be a turbulent environment for seeded cells near the periphery of the scaffold due to high shear forces. Earlier in the paper we described the perfusion bioreactor, and how it is used to maintain the scaffold’s environment of cell culture conditions, obtain a more even cell distribution through a uniform rate of perfusion, and increase nutrient delivery to the whole scaffold. Currently, many studies involve seeding hMSCs on various types of scaffolds. Two studies focused on seeding hMSCs on decellularized bone. One study conducted on decellularized bovine trabecular bone showed that the rate of perfusion during cultivation increases the amount of cells, cell distribution throughout the constructs as well as increases in osteopontin and collagen expression [72]. Another study implanted a fully decellularized scaffold in the temporomandibular joint of the condylar bone as the tissue model and showed tissue growth by the formation of confluent layers of lamellar bone and formation of osteoids. Cells were fully viable at a physiologic density [73]. Another technique develops a method for an aggregated cell-containing construct in a perfusion bioreactor system. HMSCs are encapsulated in tightly packed alginate beads. These form a single construct or tubular growth chamber where nutrient transfer is enhanced and the cells are exposed to shear stress [74, 75]. Results show that the cells in the perfusion bioreactor indicated early osteoblastic differentiation, as well as a significant increase in gene expression levels of osteocalcin, osteopontin, and bone morphogenetic protein 2 (BMP-2) in the culture, which increased with increased perfusion rates [75]. In the perfusion culture, fluid flow can exert shear stress on the cells seeded on the scaffold, improving the mass transport of the cells [76]. One study showed that increasing flow shear stress accelerated osteogenic differentiation and improved the mineralization of the extracellular matrix (ECM) [76]. A similar study showed that bioreactor-cultured scaffold reached cellular confluence earlier, with greater cellularity, and maintained high cellular viability in the core. Additionally, bioreactor culture was associated with greater osteogenic induction, alkaline phosphatase expression, and bony nodule formation, and in vivo ectopic bone formation in immunodeficient mice, compared with the static-cultured scaffold [77]. A recent study utilized two perfusion flow conditions (parallel flow [PF] and transverse flow [TF]) to understand the impact of flow configuration of cellular construct development during both preculture and in growth media, and how it affects osteogenic induction. The TF reduced cell proliferation and osteogenic induction in the preculture. In contrast, PF maintained cell proliferation under the osteogenic induction but

6


resulted in localized cell aggregation, influencing osteogenic differentiation [78]. This is most likely due to the fact that the forces experienced by the cells with TF are damaging to the cells, while PF produces forces that do not damage the cells, but allow nutrients to be more evenly distributed throughout the construct. Most studies conducted with perfusion bioreactors are in vitro studies, though in vivo studies provide critical information for clinical applications. In one study, a perfusion cultured scaffold made of natural coral was transplanted subcutaneously in sheep; the bone constructs were shown to be osteogenic [79]. A similar study using a sheep model evaluated the effect of a large perfusion bioreactor on the posterolateral spine. The study saw a significant increase in bone density and trabecular thickness than non-implanted bone substitutes [80]. Perfusion bioreactors serve as a promising method for custom bone constructs, spine fusion procedures, bone grafts, craniofacial and orthopedic applications. Studies have shown that compression bioreactors can also be used for the purpose of cell proliferation for osteogenic differentiation. Our group used a scaffold subjected to dynamic mechanical compression previously demonstrated to induce chondrogenic and osteogenic differentiation. Results showed that inhibiting ERK1/2 augments osteogenic cell response and significantly increases their expression of alklaline phosphatase, collagen type I, and osteocalcin confirmed by histochemical staining [81]. In a comparative study of a perfusion and compression bioreactor, results indicate that the perfusion and on-off cyclic mechanical stimulation maintain cell viability and promote proliferation, though the perfusion group had the highest tensile modulus, higher cell density, and higher degree of cell proliferation [82], reaffirming the promising results of the perfusion bioreactor. Rotating-wall vessel (RWV) bioreactors are also promising in the field of osteogenic differentiation because these bioreactors have high rates of mass transfer and small shear loads. A very recent study saw bone tissue containing vascular-like structures was generated, providing cells with an advantage in the construction of 3D bone tissue with blood vessels [83]. Another group showed the number of cells cultured in the bioreactor was five times higher than those cultured in a T-flask. The tissue-engineered bone grew very well in the bioreactor [84]. A unique study used a NASAapproved RWV to develop osteoblast-like cell cultures under microgravity and evaluated osteoblast phenotype and cell function. The rat osteoblast-like cell line was grown in the RWV at gravity of 0. 008g. Results showed that cells under microgravity experienced reduced osteoblast life span which may result in inefficient osteoblast and increased osteoclast activity. This is potentially what contributes to bone loss in individuals subjected to long periods of weightlessness [85]. The study shows that inhibiting the force of gravity on the bone inhibits the differentiation of bone cells and the strength of the bone construct. Due to these conflicting studies, it is hard to determine the true potential of the rotating wall vessel bioreactor, for the growth of TE bone constructs.

Ruiz et al.

CARTILAGE BIOREACTORS Adult cartilage has a limited healing capacity. Damages resulting from disease or injury increase over time and cause severe pain [86] Currently there is no surgical procedure available to treat large and deep cartilage defects associated with advanced diseases such as osteoarthritis [87]. For this reason cartilage tissue bioreactors serve as a promising means for the successful regeneration of damaged or diseased cartilage. Different methodologies for tissue engineering of cartilage have been previously and extensively reviewed in detail [88]. In this review paper however, we focus on those applications which pertain directly to the use of bioreactors for the field of cartilage engineering. A variety of bioreactor systems including the perfusion, cyclic compression, dynamic compression, hydrostatic pressure, and hydrodynamic pressure bioreactors have been implemented to induce chondrogenic differentiation. A perfusion bioreactor is used in the field of cartilage tissue engineering as a design mechanism to perfuse a cell suspension directly through the pore of a three-dimensional scaffold as well as perfuse culture media to maintain cell viability within the seeded construct [87]. One study seeded human chondrocytes through a 50 mm diameter scaffold. Results showed that these tissues grown in the bioreactor were viable and homogenously cartilaginous, with biomechanical properties such as those of native cartilage. Contrastingly, the tissues generated by conventional manual production in this study were inhomogeneous and contained large necrotic regions [87]. A similar study used a recirculating flow-perfusion bioreactor was used to stimulate the motion of a native diarthrodial joint by offering shear stress and hydrodynamic pressure simultaneously [89]. They found that cells in the perfusion bioreactor showed significantly better cell morphology and zonal organization, as well as presented more characteristics of native articular cartilage [89]. In yet another study, chondrocytes and osteoblasts composites were co-cultured using a perfusion bioreactor. Results showed that the chondrocytes and osteoblasts showed fine adhesive progression and proliferation in a β-tricalcium phosphate (βTCP) scaffold [90]. Therefore the perfusion bioreactor is deemed beneficial because it provides sustained nutrient supply and gas exchange into the center of a large scaffold, allowing the chondrocytes and osteoblasts to survive and proliferate. Two studies seeded human chondrocytes on polyglycolic acid (PGA) scaffold and cultured the cells in perfusion bioreactors. One study showed that gradually increasing the flow rate resulted in larger constructs, an increase in glycosaminoglycan (GAG) retained in the extracellular matrix, and an increase in GAG concentration in the tissues compared to the control [91]. The other study pre-cultured the cells in shaking T-flasks and perfusion bioreactors, showing that mechanical treatment improved the amount and quality of cartilage produced in comparison of both culture methods. Results also showed that the perfusion bioreactor proved more beneficial in producing collagen type II [92]. Recent studies have set out to compare the synergistic effects of a perfusion bioreactor and mechanical stimulation on the properties of TE cartilage. One group centrifuged high-density porcine chondrocytes onto an agarose layer. The results showed that the constructs cultured in the biore-



7

Fig. (2). A) Schematics for sinusoidal compression bioreactor used in the stimulation of multipotent stem cells to a chondrogenic and osteogenic lineage. B) Loading configuration for compression of constructs [95].

actor exhibited an increase in total GAG content, equilibrium compressive modulus, and dynamic modulus in comparison to the static constructs [93]. A different study tested the confluence of perfusion and mechanical stimulation on bone marrow stromal cells seeded on a collagen meniscus implant. Results showed proliferation using continuous perfusion and differentiation if also fostered by mechanical stimulation [94]. Studies on cyclic compression bioreactors have shown that they can be used for the purpose of cell proliferation for chondrogenic differentiation. Our group studied the effects of cyclic compression on these very properties. (Fig 2) Human Mesenchymal Stem Cells (HMSCs) were seeded in the scaffold and subject to cyclic compression. Three concentrations of fibrin gel and three different stimulus frequencies were used to examine the effects of cyclic compression on viability, proliferation and chondrogenic differentiation of hMSCs. Results show that cyclic compression at frequencies >0. 5 Hz and gel concentration of 40 mg/mL fibrinogen appears to maintain cellular viability within scaffolds [95, 96].

Another study embedded hMSCs in a fibrin/polyurethane scaffold and applied compression, shear, or a combination of both stimuli. Both compression and shear alone proved insufficient for chondrogenic induction of hMSCs, though the application of shear superimposed upon dynamic compression lead to significant increases in chondrogenic gene expression. Histological analysis detected sulphated glycosaminoglycan and collagen II only in the combined compression and shear group [97]. Stimulating scaffolds with a bioreactor which simulates natural joint movements holds great potential to produce cartilage. This is the reason dynamic compression bioreactors prove promising in the field of cartilage tissue engineering. One study used two methods based on atomic force microscopy (AFM) to obtain information about the quality of the engineered cartilage surface [98]. Bovine chondrocytes were seeded on polyurethane scaffolds and subjected to dynamic compression applied by a ceramic ball in loading group 1 (LG1), and dynamic compression applied with a ball oscillating over the scaffold generating a sliding motion in

8


loading group 2 (LG2). Results showed the presence of collagen type II and aggrecan staining in all constructs, and appeared to be deeper area in loaded constructs versus the unloaded scaffolds. Sliding-type biomechanical movement favors regeneration and maintenance of functional articular surfaces and supports the development of mechanically competent engineered cartilage [98]. Another study seeded porcine chondrocytes in hydroxyapatite carriers, resulting in scaffold-free cartilage-carrier constructs which were placed in a custom-made bioreactor. Results showed that the highest compression amplitude of 20% had the strongest positive effect on the mechanical properties of the TE cartilage compared to the unloaded control [86]. The data suggests that preconditioning with higher load amplitudes might be a promising method of generating stiffer tissue and may assist in accelerating the cultivation of mechanically competent tissue engineered cartilage. Different methodologies for tissue engineering of cartilage using hydrostatic pressure (HP) bioreactors have been previously and extensively reviewed in detail involving the chondroprotective effects of HP, the use of HP for chondrogenic differentiation, and HP mechanotrasnduction [99]. One group seeded MSCs in type I collagen sponges and exposed them to HP. Results showed that with HP loading, proteoglycan staining increased markedly. Also results showed that genes associated with chondrogenic differentiation, including aggrecan, type II collagen, and Sox 9 increased significantly [100]. A similar study was conducted on an alginate hydrogel scaffold seeded with bovine articular chondrocytes. Results show that the Ca2+ signaling response to direct perfusion of chondrocytes-seeding scaffolds increased with flow rate and was found more directly dependent on fluid velocity rather than shear stress or hydrostatic pressure [101]. The data suggests that flow-induced Ca2+ signaling response of chondrocytes may be due to mechanical signaling pathways, influenced by the 3D nature of cell shape. A different group used ovine bone marrow mesenchymal cells (BMMCs) and seeded them in non-woven filamentous plasma treated polyester scaffolds and applied pulsatile HP [102]. Results showed that the glycosaminoglycan (GAG) content, the deoxyribonucleic acid (DNA) content, and the collagen content increased after the application of pulsatile HP. The data suggests that a light pulsatile HP applied at a low frequency has a cumulative stimulatory effect on the BMMCs metabolic activities including cell proliferation and synthesis of the extracellular matrix. Hydrodynamic conditions mimic the motion-induced flow fields between the articular surfaces in the synovial joint and induce formation of a distinct superficial layer in tissue engineered cartilage hydrogels with enhanced production of cartilage matrix proteoglycan and type II collagen. One study used chondrocytes-seeded agarose hydrogels and cultured them in a hydrodynamic pressure bioreactor. Results showed enhanced metabolism of type II collagen and proteoglycans, including aggrecan and a surface protein Proteoglycan 4, and induces a distinct superficial layer with enhanced collagen alignment [103]. A similar study engineered cartilage constructs and cultivated them in four well-defined hydrodynamic environments within a bioreactor [104]. The results suggested that even for similar composition, constructs could exhibit different mechanical properties due to

Ruiz et al.

differences in their ultrastructure that can be modulated by hydrodynamic parameters. Improved mechanical properties were observed in constructs placed in the hydrodynamic pressure bioreactor. A recently developed bioreactor is capable of conducting dynamic stimulation and mechanical evaluation into a single batch-testing research platform [105]. This mechanoactive transduction and evaluation bioreactor (MATE) provides accurately applied static and dynamic loading of six specimens with minimal hardware. Though not much testing has been conducted with MATE, this bioreactor proves promising in the field of cartilage engineering because it can efficiently map the biomechanical development of tissue engineered constructs during longterm culture. NEURAL BIOREACTORS The field of Neural TE is different to that of other TE fields in that the complexity and delicacy of the neural connections of the central and peripheral nervous systems (CNS, PNS) make constructs and transplant of those constructs a bigger challenge. The application of bioreactors to this field reflects this as well. While bioreactors in other TE fields stimulate and preload constructs, neural TE bioreactors focus mainly on the culturing and proliferation of Neural Stem Cells (NSCs) and Neural Progentiors (NPs) to produce enough cells to be clinically applicable and relevant. The culture of NSCs and NPs has been developed for quite some time, and it is now known that they grow best in 3D cultures [106]. When grown in suspension, both cell types have a tendency to aggregate into large cell bodies known as neural spheres, or neurospheres. Bioreactors in the field are used to control the growth, proliferation, size, and phenotype of these neurospheres, and are mostly either spinner-flask bioreactors—also known as suspension bioreactors in this field—or rotating wall vessel (RWV) bioreactors. As previously mentioned in other sections, the role of RWV bioreactors, which cancel out most forces acting on constructs and simulate microgravity, is somewhat debated within the literature. Because of mechanotransduction and its effect on cell development, studies argue that this bioreactor is detrimental to cellular proliferation and differentiation, particularly in the area of bone growth. However, many studies have shown that this bioreactor actually increases cell proliferation and alters phenotype positively. This is the case in Neural TE. One study, for example, found that if grown on traditional tubular or cylindrical scaffolds, culture in the RWV led to a decrease in proliferation of the cells compared to static cultures. A special spiral scaffold developed by the group however, showed increased cell proliferation in the static culture and an even greater proliferation when cultured in RVW [107]. One other study suggests that a microgravity environment stimulates mitochondrial activity in NSCs, as evidenced by an increase in mitochondrial gene expression [108]. Yet another study found that culturing NPs in an RWV bioreactor led to formation of larger neurospheres and higher DNA content that in static culture [109]. It is interesting to also note that these neurospheres did not form tumors when implanted into immunodeficient mice, as some neurospheres with stem cell or stem cell-like precursor cells tend to do. Regarding cell phenotype, one study found that growing NSCs in a RWV bioreactor led to a ten-fold greater


number of cells which were positive for Nestin, TuJ1, and GFAP, all critical neural factors. Those cells expressing TuJ1 had extensive neurite outgrowth, suggesting the strong role that this kind of bioreactor can have in the development of neural-like constructs [110]. This study also showed that at the beginning, cultures grown in this type of bioreactor exhibited a lag in cellular differentiation, but caught up and surpassed static cultures at around week 3. This suggests that in order to harness the full power of such a bioreactor, a better understanding of the mechanisms and time points of this bioreactor on the development of neural constructs is required. It has been known for some time that spinner flask (suspension) bioreactors can be used to increase the proliferation rate of neural stem cells and neural progenitors, as well as control the size of neurospheres. The ideal media and passaging conditions for culturing such constructs in suspension bioreactors have also been previously researched and developed [111, 112]. The role of suspension bioreactors on the culture and scale-up of NSCs and NPs has also been previously reviewed, though not recently [113]. One of the biggest advantages to growing neurospheres in spinning flask bioreactors is the ability to control the size of the neurospheres. Studies have found that the shear forces experienced by the neurospheres in these bioreactors limits the size of to which these neurospheres grow [114]. This study also showed that an increase in agitation rate leads to the decrease of neurosphere diameter. This is critical as larger neurospheres develop necrotic cores, due to a decrease in the diffusion of nutrients to the center of the sphere. Another clear advantage to this kind of 3D culture is the ability to upscale suspension bioreactors [115, 116]. The same group that studied upscalability in this bioreactor type found that the ideal stirring rate is that of 100 rpms, at which point cultured cells maintain Nestin expression after culture and expansion and can still differentiate in glial and neural phenotypes. While these two bioreactors dominate the field and are used most extensively, there have been studies using other kinds of bioreactors. Studies have used a perfusion bioreactor to constantly perfuse cells [117, 118]. Both studies found an increase in cell viability and proliferation due to medium perfusion. One study also discovered that shear rates that were too high decreased viability, suggesting that while fresh media perfusion increases nutrient delivery and waste removal, high shear stresses are detrimental to the cells [118]. Another study is the only study that we are aware of that uses mechanical stimulation in this field. Cells were seeded on the edge of a surface and allowed to attach and grow. The axons of said cells, when attached to the stationary bottom edge, were then stretched by the very small stretching of the top layer on which the cell bodies were seeded. The publication is a video publication, and the design of the bioreactor, as well as accelerated video of the stretching axons, is available online, and presents the interesting, and previously unexplored area of mechanical stimulation of neurons [119]. Another study looked at the effect of hydrostatic pressure on myelination. This however, was done not with a TE goal in mind, but to better understand myelination and demyelination in injury models. They found that this kind of biophysical stimulation induces demyelination and Schwann cell proliferation [120].


9

CONCLUSION In the past ten years, little has changed in the design of the major bioreactor modalities. Perfusion, mechanical stretching, electrical stimulation, rotating wall vessel, and spinner flask bioreactors all remain the same in basic design and concept. While recent studies have claimed to develop novel or new bioreactors, the truth remains that no groundbreaking bioreactor designs have been made recently. What has evolved however, is our understanding of the value that each of these bioreactor modalities has for different tissue engineering applications. The perfusion bioreactor, for example, has the widest range of applications, as it provides homogenous nutrient transport and cell seeding throughout the construct, regardless of cell type or scaffold material. Others, such as the electrical stimulation bioreactor, are more restricted to the fields of cardiac and muscular tissue engineering. What has also advanced is the ways in which bioreactors are applied and used. As our understanding of the different forces and signals which play a role in tissue development increases, so does our understanding of the ways in which we can apply the bioreactor designs available for optimal tissue development and integration. The biggest advances in bioreactor use and development have perhaps then, been in those areas in which multimodal bioreactors have been developed. The most novel bioreactor designs are those which incorporate multiple forms of stimulation in synch, such as mechanical and electrical stimulation for muscle development. These are the bioreactors which point to the future of the field. In a few years, the perfusion bioreactor will probably disappear as a stand-alone bioreactor, and rather become a feature that all new bioreactor designs incorporate, as was seen in some of the multimodal cardiac bioreactors. Perhaps we might even see the development of a new tissue culture incubator with easy access perfusion as an option for all culture types. Bioreactors which more closely monitor multiple stimuli will usher in the next generation of bioreactors that will aid in the development of replacement tissues that will have better incorporation and function once implanted into sites of disease and injury. CONFLICT OF INTEREST The authors confirm that this article content has no conflicts of interest. ACKNOWLEDGEMENTS Declared none. REFERENCES [1] [2] [3] [4] [5]

Langer R, Vacanti JP. “Tissue Engineering. ” Science. 1993 May 14; 260(5110):920:-6. Chen CS, Tan J, Tien J. “Mechanotransduction at Cell-Matrix and Cell-Cell Contacts. ” Annual Review of Biomedical Engineering. 2004; 6:275-302. Murphy SV, Atala A. “Organ Engineering – Combining Stem Cells, Biomaterials, and Bioreactors to Produce Bioengineered Organs for Transplantation. ” 2012 Sep 20. Freed LE, Guilak F, Guo XE, et al. “Advanced Tools for Tissue Engineering: Scaffolds, Bioreactors, and Signaling. ” Tissue Engineering. 2006 Dec; 12(12):3285-305. Riehl BD, Park JH, Kwon IK, Lim JY. “Mechanical Stretching for Tissue Engineering: Two-Dimensional and Three-Dimensional

10

[6] [7] [8]

[9] [10]

[11]

[12]

[13]

[14]

[15] [16]

[17]

[18] [19] [20] [21] [22] [23]

[24]

[25]

Current Tissue Engineering, 2013, Vol. 2, No. 2 Constructs. ” Tissue Engineering Part B Review. 2012 Aug; 18(4):288-300. Vandenburgh HH. “Dynamic Mechanical Orientation of Skeletal Myofibers in vitro. ” Developmental Biology. 1982 Oct; 93(2):43843. Leonard EK, Pai VH, Amberg P, Gardner J, Orwin EJ. “Design and Validation of a Corneal Bioreactor. ” Biotechnology and Bioengineering. 2012 Dec; 109(12):3189-98. Wozniak AC, Kong J, Bock E, Pilipowicz O, Anderson JE. “Signaling Satellite-Cell Activation in Skeletal Muscle: Markers, Models, Stretch, and Potential Alternate Pathways. ” Muscle & Nerve. 2005 Mar; 31(3):283-300. Dennis RG, Smith B, Philip A, Donnelly K, Baar K. “Bioreactors for Guiding Muscle Tissue Growth and Development. ” Advances in Biochemical Engineering/Biotechnology. 2009; 112:39-79. Valdes JA, Gaggero E, Hidalgo J, Leal N, Jaimovich E, Carrasco MA. “NFAT Activation by Membrane Potential Follows a Calcium Pathway Distinct from other Activity-related Transcription Factors in Skeletal Muscle Cells. ” American Journal of Physiology, Cell Physiology. 2008 Mar; 294(3):C715-25. Huang YC, Dennis RG, Baar K. “Cultured Slow vs. Fast Skeletal Muscle Cells Differ in Physiology and Responsiveness to Stimulation. ” American Journal of Physiology, Cell Physiology. 2006 Jul; 291(1):C11-7. Vandenburgh HH, Karlisch P. “Longitudinal Growth of Skeletal Myotubes in vitro in a New Horizontal Mechanical Cell Stimulator. ” In vitro Cellular and Developmental Biology: Journal of the Tissue Culture Association. 1989 Jul; 25(7):607-16. Candiani G, Riboldi SA, Sadr N, et al. “Cyclic Mechanical Stimulation Favors Myosin Heavy Chain Accumulation in Engineered Skeletal Muscle Constructs. ” Journal of Applied Biomaterials and Biomechanics. 2010 May-Aug; 8(2):68-75. Hornberger TA, Armstrong DD, Koh TJ, Burkholder TJ, Esser KA. “Intracellular Signaling Specificity in Response to Uniaxial vs. Multiaxial Stretch: Implications for Mechanotransduction. ” American Journal of Physiology. Cell Physiology. 2005 Jan; 288(1):C185-94. Moon du G, Christ G, Stitzel JD, Atala A, Yoo JJ. “Cyclic Mechanical Preconditioning Improves Engineered Muscle Contraction. ” Tissue Engineering. Part A. 2008 Apr; 14(4): 473-82. Machinigal MA, Corona BT, Walters TJ, et al. “A TissueEngineered Muscle Repair Construct for Functional Restoration of an Irrecoverable Muscle Injury in a Murine Model. ” Tissue Engineering. Part A. 2011 Sep; 17(17-18):2291-303. Corona BT, Machinigal MA, Criswell T, et al. “Further Development of a Tissue Engineered Muscle Repair Construct in vitro for Enhanced Functional Recovery Following Implantation in vivo in a Murine Model of Volumetric Muscle Loss Injury. ” Tissue Engineering. Part A. 2012 Jun; 18(11-12):1213-28. Passey S, Martin N, Player D, Lewis MP. “Stretching Skeletal Muscle in vitro: Does it Replicate in vivo Physiology?” Biotechnology Letters. 2011 August; 33(8):1513021. Dennis RG, Dow DE. “Excitability of Skeletal Muscle During Development, Denervation, and Tissue Culture. ” Tissue Engineering. 2007 Oct; 13(10):2395-404. Fujita H, Nedachi T, Kanzaki M. “Accelerated de novo sarcomere assembly by electric pulse stimulation in C2C12 myotubes. ” Experimental Cell Research. 2007 May 15; 313(9):1853-65. Bayol S, Brownson C, Loughna PT. “Electrical Stimulation Modulates IGF Binding Protein Transcript Levels in C2C12 Myotubes. ” Cell Biochemistry and Function. 2005 Sep-Oct; 23(5):361-5. Donnelly K, Khodabukus A, Philp A, Deldicque L, Dennis RG, Baar K. “A Novel Bioreactor for Stimulating Skeletal Muscle in vitro. ” Tissue Engineering. Part C, Methods. 2010 Aug; 16(4):711-8. Cimetta E, Flaibani M, Mella M, et al. “Enhancement of Viability of Muscle Precursor Cells on 3D scaffold in a perfusion bioreactor. ” The International Journal of Artificial Organs. 2007 May; 30(5):415-28. Flaibaini M, Luni C, Sbalchiero E, Elvassore N. “Flow Cytometric Cell Cycle Analysis of Muscle Precursor Cells Cultured within 3D scaffolds in a Perfusion Bioreactor. ” Biotechnology Progress. 2009 Jan-Feb; 25(1):286-95. Rippel RA, Ghanbari H, Seifalian AM. “Tissue-engineering heart valve: future of cardiac surgery. ” World Journal of Surgery. 2012 Jul; 36(7):1581-91.

Ruiz et al. [26] [27]

[28] [29]

[30]

[31]

[32]

[33]

[34] [35] [36] [37]

[38]

[39] [40] [41]

[42]

[43]

[44]

[45]

[46]

Vesely I. “Heart Valve Tissue Engineering. ” Circulation Research. 2005 Oct 14; 97(8):743-55. Gandaglia A, Bagno A, Naso F, Spina M, Gerosa G. “Cells, scaffolds, and bioreactors for tissue-engineered heart valves: a journey from basic concepts to contemporary developmental innovations. ” European Journal of Cardio-Thoracic Surgery. 2011 Apr; 39(4):523-31. Sacks MS, Schoen FJ, Mayer JE. “Bioengineering Challenges for Heart Valve Tissue Engineering. ” Annual Review of Biomedical Engineering. 2009; 11:289-313. Balachandran K, Konduri S, Sucosky P, Jo H, Yoganathan AP. “An ex vivo study of the biological properties of porcine aortic valves in response to circumferential cyclic stretch. ” Annals of Biomedical Engineering. 2006 Nov; 34(11):1655-65 Engelmayr GC, Sales VL, Mayer JE Jr, Sacks MS. “Cyclic Flexure and Laminar Flow Synergistically Accelerate Mesenchymal Stem Cell-Mediated Engineered Tissue Formation: Implications for Engineered Heart Valve Tissues. ” Biomaterials. 2006 Dec; 27(36):6083-95. Gould RA, Chin K, Santisakultarm TP, et al. “Cyclic strain anisotropy regulates valvular interstitial cell phenotype and tissue remodeling in three-dimensional culture. ” Acta Biomaterialia. 2012 May; 8(5):1710-9. Thayer P, Balachandran K, Rathan S, et al. “The Effects of Combined Cyclic Stretch and Pressure on the Aortic Valve Interstitial Cell Phenotype. ” Annals of Biomedical Engineering. 2011 Jun; 39(6):1654-67. Balachandran K, Bakay MA, Conolly JM, Zhang X, Yoganathan AP, Levy RJ. “Aortic Valve Cyclic Stretch Causes Increased Remodeling Activity and Enchanced Serotonin Receptor Responsiveness. ” Annals of Thoracic Surgery. 2011 Jul; 92(1):147-53. Syedain ZH, Tranquillo RT. “Controlled Cyclic Stretch Bioreactor for Tissue-Engineered Heart Valves. ” Biomaterials. 2009 Sep; 30(25):4078-84. Vismara R, Soncini M, Talo G, et al. “A bioreactor with compliance monitoring for heart valve grafts. Annals of Biomedical Engineering. 2010 Jan; 38(1):100-8. Ruel J, Lachance G. “A New Bioreactor for the Development of Tissue-Engineered Heart Valves. ” Annals of Biomedical Engineering. 2009 Apr; 37(4):674-81. Sierad LN, Simionescu A, Albers C, et al. “Design and Testing of a Pulsatile Conditioning System for Dynamic Endothelialization of Polyphenol-Stabilized Tissue Engineered Heart Valves. ” Cardiovascular Engineering and Technology. 2010 Jun; 1(2):138-153. Warnock JN, Konduri S, He Z, Yoganathan AP. “Design of a Sterile Organ Culture System for the Ex Vivo Study of Aortic Heart Valves. ” Journal of Biomechanical Engineering. 2005 Oct; 127(5):857-61. Lee DJ, Steen J, Jordan JE, et al. “Endothelialization of a Heart Valve Matrix Using a Computer-Assisted Pulsatile Bioreactor. ” Tissue Engineering. Part A. 2009 Apr; 15(4):807-14. Karim N, Golz K, Bader A. “The Cardiovascular Tissue-Reactor: A Novel Device for the Engineering of Heart Valves. ” Artificial Organs. 2006 Oct; 30(10):809-14. Flanagan TC, Cornelissen C, Koch S, et al. “The in vitro development of autologous fibrin-based tissue-engineering heart valves through optimised dynamic conditioning. ” Biomaterials. 2007 Aug; 28(23):3388-97. Mol A, Driessen NJ, Rutten MC, Hoerstrup SP, Bouten CV, Baaijens FP. “Tissue Engineering of Human Heart Valve Leaflets: A Novel Bioreactor for a Strain-Based Conditioning Approach. ” Annals of Biomedical Engineering. 2005 Dec; 33(12):1778-88. Aleksieva G, Hollweck T, Thierfelder N, et al. “Use of a Special Bioreactor for the Cultivation of a New Flexible Polyurethane Scaffold for Aortic Valve Tissue Engineering. ” Biomedical Engineering Online. 2012 Dec 4; 11:92. Dean EW, Udelsman B, Breuer CK. “Current Advances in the Translation of Vascular Tissue Engineering to the Treatment of Pediatric Congenital Heart Disease. ” Yale Journal of Biology and Medicine. 2012 Jun; 85(2):229-38. Bilodeau K, Couet F, Boccafoschi F, Mantovani D. “Design of a Perfusion Bioreactor Specific to the Regeneration of Vascular Tissues Under Mechanical Stresses. ” Artificial Organs. 2005 Nov; 29(11):906-12. Seliktar D, Black RA, Vito RP, Nerem RM. “Dynamic Mechanical Conditioning of Collagen-gel Blood Vessel Constructs Induces


[47]

[48] [49]

[50]

[51]

[52]

[53] [54]

[55]

[56] [57]

[58]

[59] [60]

[61]

[62]

[63] [64] [65]

[66]

Remodeling in vitro. ” Annals of Biomedical Engineering. 2000 Apr; 28(4):351-62. Webb AR, Macrie BD, Ray AS, et al. “In vitro Characterization of a Compliant Biodegradable Scaffold with a Novel Bioreactor System. ” Annals of Biomedical Engineering. 2007 Aug; 35(8):135767. Williams C, Wick TM. “Perfusion Bioreactor for Small Diameter Tissue-Engineered Arteries. ” Tissue Engineering. 2004 May-Jun; 10(5-6):930-41. Song L, Zhou Q, Duan P, et al. “Successful Development of Small Diameter Tissue-Engineering Vascular Vessels by our Novel Integrally Designed Pulsatile Perfusion-based Bioreactor. ” PLoS One. 2012; 7(8). Optiz F, Schenke-Layland K, Richter W, et al. “Tissue Engineering of Ovine Aortic Blood Vessel Substitutes Using Applied Shear Stress and Enzymatically Derived Vascular Smooth Muscle Cells. ” Annals of Biomedical Engineering. 2004 Feb; 32(2):212-22. Boerboom RA, Rubbens MP, Driessen NJ, Bouten CV, Baaijens FP. “Effect of Strain Magnitude on the Tissue Properties of Engineered Cardiovascular Constructs. ” Annals of Biomedical Engineering. 2008 Feb; 36(2):244-53. Groeber F, Kahlig A, Loff S, Walles H, Hansmann J. “A Bioreactor System for Interfacial Culture and Physiological Perfusion of Vascularized Tissue Equivalents. ” Biotechnology Journal. 2012 Oct 10. Hecker L, Birla RK. “Engineering the Heart Piece by Piece: State of the Art in Cardiac Tissue Engineering. ” Regenerative Medicine. 2007 Mar; 2(2):125-44. He W, Ye L, Li S, et al. “Stirred Suspension Culture Improves Embryoid Body Formation and Cardiogenic Differentiation of Genetically Modified Embryonic Stem Cells. ” Biological & Pharmaceutical Bulletin. 2012; 35(3):308-16. Shafa M, Krawetz R, Zhang Y, et al. “Impact of Stirred Suspension Bioreactor Culture on the Differentiation of Murine Embryonic Stem Cells into Cardiomyocytes. ” BMC Cell Biology. 2011 Dec 14; 12:53. Dvir T, Benishti N, Shachar M, Cohen S. “A Novel Perfusion Bioreactor Providing a Homogenous Milieu for Tissue Regeneration. ” Tissue Engineering. 2006 Oct; 12(10):2843-52. Cheng M, Morett M, Engelmayr GC, Freed LE. “Insulin-like Growth Factor-I and slow, bi-directional perfusion enhance the formation of tissue-engineered cardiac grafts. ” Tissue Engineering. Part A. 2009 Mar; 15(3):645-53. Carrier RL, Rupnick M, Langer R, Schoen FJ, Freed LE, VunjakNovakovic G. “Perfusion Improves Tissue Architecture of Engineered Cardiac Muscle. ” Tissue Engineering. 2002 Apr; 8(2):17588. Birla RK, Huang YC, Dennis RG. “Development of a Novel Bioreactor for the Mechanical Loading of Tissue-Engineered Heart Muscle. ” Tissue Engineering. 2007 Sep; 13(9):2239-48. Tandon N, Marsano A, Cannizzaro C, Voldman J, VunjakNovakovic G. “Design of Electrical Stimulation Bioreactors for Cardiac Tissue Engineering. ” IEEE Engineering in Medicine and Biology Society. Conference Proceedings. 2008; 2008:3594-7. Tandon N, Marsano A, Maidhof R, Wan L, Park H, VunjakNovakovic G. “Optimization of Electrical Stimulation Parameters for Cardiac Tissue Engineering. ” Journal of Tissue Engineering and Regenerative Medicine. 2011 Jun; 5(6):e115-25. Serena E, Figallo E, Tandon N, et al. “Electrical Stimulation of Human Embryonic Stem Cells: Cardiac Differentiation and the Generation of Reactive Oxygen Species. ” Experimental Cell Research. 2009 Dec 10; 315(20):3611-9. Tandon N, Marsano A, Maidhof R, et al. “Surface-patterned electrode bioreactor for electrical stimulation. ” Lab on a Chip. 2010 Mar 21; 10(6):692-700. Mooney E, Mackle JN, Blond DJ, et al. “The Electrical Stimulation of Carbon Nanotubules to Provide a Cardiomimetic cue to MSCs. ” Biomaterials. 2012 Sep; 33(26):6132-9. Pedrotty DM, Koh J, Davis BH, Taylor DA, Wolf P, Niklason LE. “Engineering Skeletal Myoblasts: Roles of Three-Dimensional Culture and Electrical Stimulation. ” American Journal of Physiology. Heart and Circulatory Physiology. 2005 Apr; 288(4):H1620-6. Kensah G, Gruh I, Viering J, et al. “A Novel Miniaturized Multimodal Bioreactor for Continuous in situ Assesment of Bioartificial Cardiac Tissue During Stimulation and Maturation. ” Tissue Engineering Part C. Methods. 2011 Apr; 17(4):463-73.

Current Tissue Engineering, 2013, Vol. 2, No. 2 [67]

[68]

[69]

[70] [71] [72] [73] [74] [75] [76]

[77] [78] [79] [80] [81]

[82]

[83] [84]

[85]

[86]

[87] [88]

11

Maidhof R, Tandon N, Lee EJ, et al. “Biomimetic Perfusion and Electrical Stimulation Applied in Concert Improved the Assembly of Engineered Cardiac Tissue. ” Journal of Tissue Engineering and Regenerative Medicine. 2012 Nov; 6(10):e12-23. Lu L, Mende M, Yang X, et al. “Design and validation of a bioreactor for stimulating the cardiac niche: a system incorporating cyclic stretch, electrical stimulation, and constant perfusion. ” Tissue Engineering Part A. 2013 Feb; 19(3-4):403-14. Barash Y, Dvir T, Tandeitnik P, Ruvinov E, Guterman H, Cohen S. “Electric Field Stimulation Integrated into Perfusion Bioreactor for Cardiac Tissue Engineering. ” Tissue Engineering Part C. Methods. 2010 Dec; 16(6):1417-26. T. Mygind, M. Stiehler, A. Baatrup, et al. “Mesenchymal stem cell ingrowth and differentiation on coralline hydroxyapatite scaffolds. ” Biomaterials 28 (2007) 1036–1047. H. J. Kim, U. J. Kim, G. G. Leisk, C. Bayan, I. Georgakoudi, D. L. Kaplan. “Bone regeneration on macroporous aqueous-derived silk 3-D scaffolds. ” Macromol. Biosci. 7 (2007) 643–655. W. L. Grayson, S. Bhumiratana, C. Cannizzaro, et al. “Effects of initial seeding density and fluid perfusion rate on formation of tissue-engineered bone. ” Tissue Eng. Part A 14 (2008) 1809–1820. W. L. Grayson, M. Frohlich, K. Yeager, et al. “Engineering anatomically shaped human bone grafts. ” Proc. Natl. Acad. Sci. U. S. A. 107 (2010) 3299–3304. 1A. B. Yeatts, C. N. Gordon, J. P. Fisher, “Formation of an aggregated alginate construct in a tubular perfusion system. ” Tissue Eng. Part C Methods 17 (2011) 1171–1178. 1A. B. Yeatts, J. P. Fisher, “Tubular perfusion system for the longterm dynamic culture of human mesenchymal stem cells. ” Tissue Eng. Part C Methods 17 (2011) 337–348. D. Li, T. Tang, J. Lu, K. Dai. “Effects of flow shear stress and mass transport on the construction of a large-scale tissue-engineered bone in a perfusion bioreactor. ” Tissue Eng. Part A 15 (2009) 2773–2783. Zhang ZY, Teoh SH, Chong WS, et al. “A biaxial rotating bioreactor for the culture of fetal mesenchymal stem cells for bone tissue engineering. ” Biomaterials 2009; 30:2694e704. J Kim, T Ma. “Bioreactor Strategy in Bone Tissue Engineering: Pre-Culture and Osteogenic Differentiation Under Two Flow Configurations. ” Tissue Eng. Part A 18 (2012) 2354-64. David B, Bonnefont-Rousselot D, Oudina K, et al. “A perfusion bioreactor for engineering bone constructs: an in vitro and in vivo study. ” Tissue Eng Part C Methods. 2011; 17:505 JR Sørensen, KE Koroma, M Ding, et al. “Effects of a perfusion bioreactor activated novel bone substitute in spine fusion in sheep. ” European Spine Journal (2012) 21:9:1740-1747. D Pelaez, C Huang, HS Cheung. “Extracellular signal-regulated kinase (ERK) dictates osteogenic and/or chondrogenic lineage commitment of mesenchymal stem cells under dynamic compression. ” Stem Cells and Development 18 (2009) 93-102. C. X. Liu, R. Abedian, R. Meister, et al. “Influence of perfusion and compression on the proliferation and differentiation of bone mesenchymal stromal cells seeded on polyurethane scaffolds. ” Biomaterials 33 (2012) 1052–1064. M Nishi, R Matsumoto, J Dong, T Uemura. “Engineered bone tissue associated with vascularization utilizing a rotating wall vessel bioreactor. ” J Biomed Mater Res A (2013) 421-7. K Song, H Wang, B Zhang, M Lim, Y Liu, T Liu. “Numerical simulation of fluid field and in vitro three-dimensional fabrication of tissue-engineered bones in a rotating bioreactor and in vivo implantation for repairing segmental bone defects. ” Cell Stress Chaperones (2012). Rucci N, Migliaccio S, Zani BM, Taranta A, Teti A. “Characterization of the osteoblast-like cell phenotype under microgravity conditions in the NASA-approved Rotating Wall Vessel bioreactor (RWV). ” J Cell Biochem. (2002) 85:167–179. Hoenig E, Winkler T, Goepfert C, et al. “High amplitude direct compressive strain enhances mechanical properties of scaffold-free tissue-engineered cartilage. ” Tissue Eng Part A. (2011) 17:1401– 11. Santoro R, Olivares AL, Brans G, et al. “Bioreactor based engineering of large-scale human cartilage grafts for joint resurfacing. ” Biomaterials 31(2010) 34: 8946-8952. Nukavarapu SP, Dorecemus DL. “Osteochondral tissue engineering: Current strategies and challenges. ” Biotechnol Adv (2012) 12: 00189-9.

12 [89] [90]

[91] [92]

[93] [94] [95]

[96]

[97]

[98]

[99] [100]

[101] [102]

[103] [104]


Ruiz et al.

Tarng YW, Huang BF, Su FC. “A novel recirculating flowperfusion bioreactor for periosteal chondrogenesis. ” Int. Orthop. (2012) 36(4):863-8. Sun S, Ren Q, Wang D, Zhang L, Wu S, Sun XT. “Repairing cartilage defects using chondrocyte and osteoblast composites developed using a bioreactor. ” Chin Med J (Engl). (2011) 124(5):75863. Shahin K, Doran PM. “Strategies for Enhancing the Accumulation and Retention of Extracellular Matrix in Tissue Engineered Cartilage Cultured in Bioreactors. ” PLoS One (2011) 6(8):e23119. Shahin K, Doran PM. “Tissue Engineering of Cartilage Using a Mechanobioreactor Exerting Simultaneous Mechanical Shear and Compression to Simulate the Rolling Action of Articular Joints. ” Biotechnol. Bioeng. (2012) 109(4):1060-73. Tran SC, Cooley AJ, Elder SH. “Effect of a Mechanical Stimulation Bioreactor on Tissue Engineered, Scaffold-Free Cartilage. ” Biotechnol. Bioeng. (2011) 108(6):1421-9. Petri M, Efer K, Toma I, et al. “Effects of perfusion and cyclic compression on in vitro tissue engineered meniscus implants. ” Knee Surg. Sports Traumatol Arthrosc. (2012) 20(2):223-31. Huang C, Hagar KL, Frost LE, Sun Y, Cheung HS. “Effects of Cyclic Compressive Loading on Chondrogenesis of Bone-Marrow Derived Mesenchymal Stem Cells. ” Stem Cells. 2004; 22(3):31323. Pelaez D, Huang CY, Cheung HS. “Cyclic Compression Maintains Viability and Induces Chondrogenesis of Human Mesenchymal Stem Cells in Fibrin Gel Scaffolds. ” Stem Cells and Development. 2009 Jan-Feb; 18(1):93-102. Schatti O, Grad S, Goldhahn J, et al. “A Combination of Shear and Dynamic Compression Leads to Mechanically Induced Chondrogenesis of Human Mesenchymal Stem Cells. ” Eur. Cell Mater (2011), 22:214-25. Grad S, Loparic M, Peter R, Stolz M, Aebi U, Alini M. “Sliding motion modulates stiffness and friction coefficient at the surface of tissue engineered cartilage. ” Osteoarthritis Cartilage (2012), 20(4):288-95. Elder BD, Athanasiou KA. “Hydrostatic Pressure in Articular Cartilage Tissue Engineering: From Chondrocytes to Tissue Regeneration. ” Tissue Eng. Part B Rev. (2009), 15(1):43-53. Wagner DR, Lindsey DP, Li KW, et al. “Hydrostatic Pressure Enhances Chondrogenic Differentiation of Human Bone Marrow Stromal Cells in Osteochondrogenic Medium. ” Ann Biomed Eng. (2008), 36(5):813-20. Degala S, Williams R, Zipfel W, Bonassar LJ. “Calcium Signaling in Response to Fluid Flow by Chondrocytes in 3D Alginate Culture. ” J Orthop. Res. (2012), 30(5):793-9. Luo ZJ, Seedhom BB. “Light and low-frequency pulsatile hydrostatic pressure enhances extracellular matrix formation by bone marrow mesenchymal cells: an in-vitro study with special reference to cartilage repair. ” Proc Inst Mech Eng H. (2007), 221(5):499507. Chen T, Hilton MJ, Brown EB, Zuscik MJ, Awad HA. “Engineering Superficial Zone Features in Tissue Engineered Cartilage. ” Biotechnol Bioeng. (2012). Bueno EM, Bilgen B, Barabino GA. “Hydrodynamic Parameters Modulate Biochemical, Histological, and Mechanical Properties of Engineered Cartilage. ” Tissue Eng Part A (2009), 15(4):773-85.

Received: ??????? ??, 201?

Revised: ????? ??, 201?

Accepted: ????? ??, 201?

[105]

[106] [107]

[108]

[109]

[110] [111]

[112] [113] [114] [115]

[116]

[117] [118] [119] [120]

Lujan TJ, Wirtz KM, Bahney CS, Madey SM, Johnstone B, Bottlang M. “A Novel Bioreactor for the Dynamic Stimulation and Mechanical Evaluation of Multiple Tissue-Engineered Constructs. ” Tissue Eng Part C Methods (2011), 17(3):367-74. Li X, Liu T, Song K, et al. “Culture of Neural Stem Cells in Calcium Alginate Beads. ” Biotechnology Progress. 2006 NovDec:22(6):1683-9 Valmikinathan CM, Hoffman J, Yu X. “Impact of scaffold micro and macro architecture on Schwann cell proliferation under dynamic conditions in a rotating wall vessel bioreactor. ” Materials Science and Engineering. 2011 Jan 1; 31(1): 22-29. Chiang MC, Lin H, Cheng YC, Yen CH, Huang RN, Lin KH. “Beta-adrenoceptor pathway enhances mitochondrial function in human neural stem cells via rotary cell culture system. ” Journal of Neuroscience Methods. 2012 Apr 5; 207: 130-136. Low HP, Savarese TM, Schwartz WJ. “ Neural Precursor Cells form rudimentary tissue-like structures in a rotating-wall vessel bioreactor. ” In vitro Cell Development Biology-Animal. 2001 Mar; 37(3): 141-147. Lin HJ, O’Shaughnessy TJ, Kelly J, Ma W. “Neural Stem Cell Differentiation in a Cell-Collagen-Bioreactor Culture System. ” Developmental Brain Research. 2004 Oct 6; 154: 163-173. Kallos MS, Behie LA. “Inoculation and Growth Conditions for High-Cell-Density Expansion of Mammalian Neural Stem Cells in Suspension Bioreactors. ” Biotechnology and Bioengineering. 1999; 63 (4): 473-483. Sen A, Kallos MS, Behie LA. “Passaging Protocols for Mammalian Neural Stem Cells in Suspension Bioreactors. ” Biotechnology Progress. 2002 Mar-Apr; 18(2):337-45. Kallos MS, Sen A, Behlie LA. “Large-scale Expansion of Mammalian Neural Stem Cells: A Review. ” Medical and Biological Engineering and Computing. 2003 May; 41(3):271-82. Sen A, Kallos MS, Behie LA. “Expansion of mammalian neural stem cells in bioreactors: effect of power input and medium viscosity. ” Brain Research Interactive. 2002; 134: 103 – 113. Gilbertson JA, Sen A, Behie LA, Kallos MS. “Scaled-up production of mammalian neural precursor cell aggregates in computercontrolled suspension bioreactors. ” Biotechnology and Bioengineering. 2006; 94(4): 783–92. Baghbaderani BA, Behie LA, Sen A, Mukhida K, Hong M, Mendez I. “Expansion of Human Neural Precursor Cells in Large-Scale Bioreactors for the Treatment of Neurodegenerative Disorders. ” Biotechnology Progress. 2008 Jul-Aug; 24(4):859-70. Cullen DK, Vukasinovic J, Glezer A, LaPlaca MC. “Microfluidic engineering high cell density three-dimensional neural cultures. ” Journal of Neural Engineering. 2007 Apr 4; 4: 159-172. Sun T, Norton D, Vickers N, et al. “Development of a Bioreactor for Evaluating Novel Nerve Conduits. ” Biotechnology and Bioengineering. 2008 Apr 1; 99(5): 1256-1259. Video: Loverde JR, Tolentino RE, Pfister BE. “Axon Stretch Growth: The Mechanotransduction of Neuronal Growth. ” J. Vis. Exp. (54), e2753, doi:10. 3791/2753 (2011). Lin MY, Frieboes LS, Forootan M, et al. “Biophysical Stimulation Induces Demyelination via an Integrin-Dependent Mechanism. ” American Neurological Association. 2012 Mar 15; 72(1): 112-123.